Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Vulvovaginal Graft-versus-Host Disease: Diagnosis and Microbiome Evaluation — Stella

Recruiting

Back to Graft Vs Host Disease trials

Trial locations(1 site)

United States

Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio

Key details

Sponsor

Case Comprehensive Cancer Center

Collaborators

Incyte Corporation

Enrollment target

~40 participants

Started

December 2024

Primary completion

August 2026

Age range

18 Years – 70 Years

Sex

Female only

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov